Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
Abroad (travel likely)RecruitingPHASE2
Conditions
Immune Thrombocytopenia · Treatment
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin, Tianjin Municipality, China
Study leads
Lei Zhang, MD
Principal Investigator
Chinese Academy of Medical Science and Blood Disease Hospital
Yunfei Chen, MD
Principal Investigator
Chinese Academy of Medical Science and Blood Disease Hospital